Evaluation of the acute- and long-term results after endovascular therapy of the popliteal artery

niversitäts-Herzzentrum Bad Krozingen0 个研究点目标入组 378 人开始时间: 2019年11月8日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Patients with peripheral arterial occlusive disease in clinical stage 1-3 according to Rutherford-Becker classification.
•- De-novo stenosis caused by arteriosclerotic disease (=70% diameter reduction) or occlusion of the popliteal artery, duplex sonographically and/or angiographically confirmed.
•- Stenosis or occlusion of the popliteal artery which not include the superficial femoral artery and/or the anterior tibial artery and/or the tibiofibular truncus.
•- At least one open, non-stenosed (=50% diameter reduction) lower leg artery on the study leg.
•- At least one follow-up examination (including duplex sonography) in a period of at least 12 months after the index procedure.

•- Patients with PAD in stage 0, 4 - 6 according to Rutherford-Becker classification.
•- Stenosis or occlusion of the poplitea artery not due to arteriosclerotic causes.
•- No relevant stenosis of the target lesion (<70% diameter reduction).
•- Ectasia or aneurysm of the poplitea artery (target lesion diameter >7mm)
•- Unsuccessful intervention of the target lesion (remaining residual stenosis =30%)
•- Re-stenosis or re-occlusion of the target lesion after previous surgical and/or endovascular therapy.
•- Treated target lesion of the poplitea artery extends to the superficial femoral artery and/or the antior tibial artery and/or the tibiofibular truncus.
•- Occlusion or relevant stenosis (>50% diameter reduction) of all lower leg arteries.
•- Limited renal function (creatinine =2.4mg/dl) or terminal renal insufficiency requiring dialysis during index procedure.
•- No follow-up imaging (duplex sonography or angiography) of the target lesion at least 12 months after the index procedure (lost-to-follow-up).

发起方

niversitäts-Herzzentrum Bad Krozingen